sulmazole has been researched along with Angina Pectoris in 3 studies
sulmazole: structure given in first source
sulmazole : An imidazopyridine that is 1H-imidazo[4,5-b]pyridine which is substituted at position 2 by a 2-methoxy-4-(methylsulfinyl)phenyl group. An A1 adenosine receptor antagonist, it was formerly used as a cardiotonic agent.
Angina Pectoris: The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stauch, M | 1 |
| Sigel, H | 1 |
| Seibold, H | 1 |
| Nechwatal, W | 1 |
| Thormann, J | 1 |
| Schlepper, M | 1 |
| Kramer, W | 1 |
| Gottwik, M | 1 |
| Kindler, M | 1 |
| Pozenel, H | 1 |
3 other studies available for sulmazole and Angina Pectoris
| Article | Year |
|---|---|
The effect of AR-L 115 BS on left ventricular function in patients with coronary heart disease and dilated cardiomyopathy.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Cardiac Catheterization; Cardiac Volume; Cardiomyopath | 1983 |
Effects of AR-L 115 BS (Sulmazol), a new cardiotonic agent, in coronary artery disease: improved ventricular wall motion, increased pump function and abolition of pacing-induced ischemia.
Topics: Angina Pectoris; Cardiac Catheterization; Cardiac Pacing, Artificial; Cardiotonic Agents; Coronary D | 1983 |
Ergometric and hemodynamic studies on a new cardiotonic agent AR-L 115 BS.
Topics: Angina Pectoris; Cardiotonic Agents; Coronary Disease; Female; Heart Diseases; Hemodynamics; Humans; | 1981 |